ロード中...
Perspectives: Other ErbB2-Targeted Therapies
SUMMARY: Despite the success of individualized targeted therapies in women with breast cancer with current available compounds, new drugs – especially with different mechanisms of resistance – are under development. A range of novel targeted agents for women with tumors that overexpress ErbB2 (HER2)...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
S. Karger GmbH
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2931098/ https://ncbi.nlm.nih.gov/pubmed/20847930 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000285779 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|